The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...

Users of the FreeStyle Libre 2 and 3 continuous glucose monitoring systems from Abbott no longer need to remove and discard the devices for imaging procedures, such as X-rays, CT ...

Abbott today announced that its FreeStyle Libre 2 and 3 systems can now be worn during common imaging procedures, such as X-rays, CT scans and MRIs*. The U.S. Food and Drug Administration (FDA) ...

Beta Bionics announced today that it launched the integration of the iLet bionic pancreas with the Abbott (NYSE:ABT) ...

Tidepool today announced a new data integration with Abbott for the company's FreeStyle Libre continuous glucose monitors ...

--(BUSINESS WIRE)--Tidepool, a software company committed to innovations in diabetes management, is thrilled to announce a ...

The shift towards glucose-sensing technology has heralded a new era in diabetes management, moving from occasional, reactive ...

Abbott’s FreeStyle Libre will likely continue to see ... s – Libre Rio and Lingo – new over-the-counter glucose monitoring devices. This should also aid the overall diabetes portfolio ...

Lastly, medical devices represent more than ... a strong leading position in their continuous glucose monitoring system with their Freestyle Libre brand. GLP-1 drugs have been rapidly adopted ...

Methods: Duplicate blood glucose measurements on the same forearm and finger as venipuncture were performed with the FreeStyle Flash ... [10 12] Glucose-monitoring devices are available that ...

It is easy to catch any significant glucose fluctuations as a CGM device ... glucose monitoring can transform your daily life. New users can try their first FreeStyle Libre sensor and unlock ...

after beating Wall Street estimates for quarterly earnings on strong demand for its continuous glucose monitors (CGMs) and other medical devices. Shares of Abbott rose 2% in afternoon trade.